Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes

DSpace/Manakin Repository

Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes

Citable link to this page

 

 
Title: Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes
Author: Chen, Lei-lei; Wu, Jun-chao; Wang, Lin-hui; Wang, Jin; Qin, Zheng-hong; Difiglia, Marian; Lin, Fang

Note: Order does not necessarily reflect citation order of authors.

Citation: Chen, Lei-lei, Jun-chao Wu, Lin-hui Wang, Jin Wang, Zheng-hong Qin, Marian Difiglia, and Fang Lin. 2012. “Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes.” Acta Pharmacologica Sinica 33 (3): 385-392. doi:10.1038/aps.2011.162. http://dx.doi.org/10.1038/aps.2011.162.
Full Text & Related Files:
Abstract: Aim: To investigate the effects of rapamycin on glutamate uptake in cultured rat astrocytes expressing N-terminal 552 residues of mutant huntingtin (Htt-552). Methods: Methods: Primary astrocyte cultures were prepared from the cortex of postnatal rat pups. An astrocytes model of Huntington's disease was established using the astrocytes infected with adenovirus carrying coden gene of N-terminal 552 residues of Huntingtin. The protein levels of glutamate transporters GLT-1 and GLAST, the autophagic marker microtubule-associated protein 1A/1B-light chain 3 (LC3) and the autophagy substrate p62 in the astrocytes were examined using Western blotting. The mRNA expression levels of GLT-1 and GLAST in the astrocytes were determined using Real-time PCR. 3H]glutamate uptake by the astrocytes was measured with liquid scintillation counting. Results: The expression of mutant Htt-552 in the astrocytes significantly decreased both the mRNA and protein levels of GLT-1 but not those of GLAST. Furthermore, Htt-552 significantly reduced 3H]glutamate uptake by the astrocytes. Treatment with the autophagy inhibitor 3-MA (10 mmol/L) significantly increased the accumulation of mutant Htt-552, and reduced the expression of GLT-1 and 3H]glutamate uptake in the astrocytes. Treatment with the autophagy stimulator rapamycin (0.2 mg/mL) significantly reduced the accumulation of mutant Htt-552, and reversed the changes in GLT-1 expression and 3H]glutamate uptake in the astrocytes. Conclusion: Rapamcin, an autophagy stimulator, can prevent the suppression of GLT-1 expression and glutamate uptake by mutant Htt-552 in cultured astrocytes.
Published Version: doi:10.1038/aps.2011.162
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077128/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12987370
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters